3,330
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Barriers and recommendations for colorectal cancer screening in Africa

&
Article: 2181920 | Received 07 Nov 2022, Accepted 14 Feb 2023, Published online: 23 Feb 2023

References

  • Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16:713–11. Epub 20190827. PubMed PMID: 31455888.
  • Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59:366–378. PubMed PMID: 19897840.
  • Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389–394. PubMed PMID: 16492934.
  • Walsh JM, Terdiman JP. Colorectal cancer screening: scientific review. JAMA. 2003;289:1288–1296. PubMed PMID: 12633191.
  • Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8. Epub 20081215. PubMed PMID: 19075198.
  • Missaoui N, Jaidaine L, Abdelkader AB, Trabelsi A, Mokni M, Hmissa S. Colorectal cancer in Central Tunisia: increasing incidence trends over a 15-year period. Asian Pac J Cancer Prev. 2011;12: 1073–1076. PubMed PMID: 21790254.
  • Agyemang-Yeboah F, Yorke J, Obirikorang C, Batu EN, Acheampong E, Frempong EA, et al. Patterns and presentations of colorectal cancer at Komfo-Anokye teaching hospital Kumasi, Ghana. Pan Afr Med J. 2017;28:121. Epub 20171006. PubMed PMID: 29515739; PubMed Central PMCID: PMC5837135.
  • Irabor D, Adedeji OA. Colorectal cancer in Nigeria: 40 years on. A review. Eur J Cancer Care (Engl). 2009;18:110–115. PubMed PMID: 19267725.
  • Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30. Epub 20170105. PubMed PMID: 28055103.
  • El Sayad HE, Ramzy Ahmed Atalla H, Mostafa Amer H. Effectiveness of nurse-led intervention on adults’ health beliefs and screening behaviors toward colorectal cancer. Egypt J Health Care. 2021;12:96–113.
  • Lambert R, Sauvaget C, Sankaranarayanan R. Mass screening for colorectal cancer is not justified in most developing countries. Int J Cancer. 2009;125:253–256. PubMed PMID: 19384945.
  • Winawer MC S, Lambert R, Fried M, Dite P, Goh KL, Guarner F, et al. World Gastroenterology Organisation/International digestive cancer alliance practice guidelines: colorectal cancer screening 2007. Available from: https://www.worldgastroenterology.org/guidelines/colorectal-cancer-screening/colorectal-cancer-screening-english.
  • Lussiez A, Dualeh SHA, Dally CK, Opoku BK, Raghavendran K, Aitpillah F, et al. Colorectal Cancer Screening in Ghana: physicians’ Practices and Perceived Barriers. World J Surg. 2021;45:390–403. Epub 20201103 PubMed PMID: 33145608; PubMed Central PMCID: PMC7609353.
  • Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US multi-society task force on colorectal cancer. Gastroenterology. 2017;152:1217–37.e3. Epub 20161019. PubMed PMID: 27769517.
  • Asombang AW, Madsen R, Simuyandi M, Phiri G, Bechtold M, Ibdah JA, et al. Descriptive analysis of colorectal cancer in Zambia, Southern Africa using the National Cancer Disease Hospital database. Pan Afr Med J. 2018;30:248. Epub 20180806. PubMed PMID: 30627309; PubMed Central PMCID: PMC6307926.
  • Saluja S, Alatise OI, Adewale A, Misholy J, Chou J, Gonen M, et al. A comparison of colorectal cancer in Nigerian and North American patients: is the cancer biology different? Surgery. 2014;156:305–310. Epub 20140619; PubMed PMID: 24953266; PubMed Central PMCID: PMC4589271.
  • Brand Bateman L, Khamess S, Abdelmoneim SE, Arafat W, Fouad MN, Khamis Y, et al. Designing an effective colorectal cancer screening program in Egypt: a qualitative study of perceptions of Egyptian primary care physicians and specialists. Oncology. 2020;25:e1525–31. Epub 20200224. PubMed PMID: 32091658; PubMed Central PMCID: PMC7543238.
  • Lussiez A, Dally CK, Boateng EA, Bosompem K, Peprah E, Hayward L, et al. Barriers to colorectal cancer screening in Ghana: a qualitative study of patients and physicians. Cancer Causes Control. 2022;33:951–958. Epub 20220412. PubMed PMID: 35415797; PubMed Central PMCID: PMC9005024.
  • May FP, Anandasabapathy S. Colon cancer in Africa: primetime for screening? Gastrointest Endosc. 2019;89:1238–1240. PubMed PMID: 31104752.
  • Nawwar A, Brand Bateman L, Khamess S, Fouad MN, Arafat WO, Abdelmonem SE, et al. Using intervention mapping to develop a theory-based intervention to promote colorectal cancer screening in Egypt. Asian Pac J Cancer Prev. 2022;23:1975–1981. Epub 20220601. PubMed PMID: 35763639.
  • Parker RK, Ranketi SS, McNelly C, Ongondi M, Topazian HM, Dawsey SM, et al. Colorectal cancer is increasing in rural Kenya: challenges and perspectives. Gastrointest Endosc. 2019;89:1234–1237. Epub 20181211. PubMed PMID: 30543780; PubMed Central PMCID: PMC7476216.
  • Alatise OI, Dare AJ, Akinyemi PA, Abdulkareem FB, Olatoke SA, Knapp GC, et al. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria. Lancet Glob Health. 2022;10:e1012–22. PubMed PMID: 35714629; PubMed Central PMCID: PMC9400038.
  • Hafez S, Taha E, Abd El Fattah N, Mohsen H, Mohsen H, Sayed E, et al. Effect of nursing interventions on health practices and perceptions regarding colorectal cancer among community-dwelling older adults in Alexandria, Egypt. Port Said Sci J Nursing. 2020;7:175–190.
  • Knapp GC, Alatise O, Olopade B, Samson M, Olasehinde O, Wuraola F, et al. Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria. PLoS ONE. 2021;16:e0243587. Epub 20210112; PubMed PMID: 33434195; PubMed Central PMCID: PMC7802943.
  • Labaeka EO, Irabor AE, Irabor DO. Fecal immunochemical test as a screening method for colorectal cancer in University College Hospital Ibadan, Nigeria. JCO Glob Oncol. 2020;6:525–531. PubMed PMID: 32216652; PubMed Central PMCID: PMC7113128.
  • Rejaibi S, Mahfoudh Mchirgui R, Ben Mansour N, Barbouch F, Kaddour N, Mrabet A, et al. Colorectal cancer mass screening, Tunisia 2019. Evaluation of a pilot program in the Tunis region (Tunisia, 2019). Tunis Med. 2021;99:158–167. PubMed PMID: 33899183).
  • Selmouni F, Amrani L, Sauvaget C, Bakkar M, El Khannoussi B, Souadka A, et al. Delivering colorectal cancer screening integrated with primary health care services in Morocco: lessons learned from a demonstration project. Cancer. 2022;128:1219–1229. doi:10.1002/cncr.34061. Epub 20220105; PubMed PMID: 34985785.
  • Adonis L, Basu D, Luiz J. Predictors of adherence to screening guidelines for chronic diseases of lifestyle, cancers, and HIV in a health-insured population in South Africa. Glob Health Action. 2014;7:23807. Epub 20140314; PubMed PMID: 24647130; PubMed Central PMCID: PMC3957800.
  • Lieberman DA, Williams JL, Holub JL, Morris CD, Logan JR, Eisen GM, et al. Colonoscopy utilization and outcomes 2000 to 2011. Gastrointest Endosc. 2014;80:133–143. Epub 20140222 PubMed PMID: 24565067.
  • Calderwood AH, Tosteson TD, Walter LC, Hua P, Onega T. Colonoscopy utilization and outcomes in older adults: data from the New Hampshire Colonoscopy Registry. J Am Geriatr Soc. 2022;70:801–811. Epub 20211203. PubMed PMID: 34859887; PubMed Central PMCID: PMC8904292.
  • Reiter PL, Katz ML, Oliveri JM, Young GS, Llanos AA, Paskett ED. Validation of self-reported colorectal cancer screening behaviors among Appalachian residents. Public Health Nurs. 2013;30:312–322. Epub 20130405 PubMed PMID: 23808856; PubMed Central PMCID: PMC3809100.
  • Alatise OI, Arigbabu AO, Agbakwuru AE, Lawal OO, Sowande OA, Odujoko OO, et al. Polyp prevalence at colonoscopy among Nigerians: a prospective observational study. Niger J Clin Pract. 2014;17:756–762. PubMed PMID: 25385915.
  • Ismaila BO, Misauno MA. Gastrointestinal endoscopy in Nigeria – a prospective two year audit. Pan Afr Med J. 2013;14:22. Epub 20130115. PubMed PMID: 23503686; PubMed Central PMCID: PMC3597902.
  • Aniwan S, Ratanachu Ek T, Pongprasobchai S, Limsrivilai J, Praisontarangkul OA, Pisespongsa P, et al. The optimal cut-off level of the fecal immunochemical test for colorectal cancer screening in a country with limited colonoscopy resources: a Multi-Center Study from Thailand. Asian Pac J Cancer Prev. 2017;18:405–412. Epub 20170201. PubMed PMID: 28345822; PubMed Central PMCID: PMC5454735.
  • Soliman AS, Raouf AA, Chamberlain RM. Knowledge of, attitudes toward, and barriers to cancer control and screening among primary care physicians in Egypt: the need for postgraduate medical education. J Cancer Educ. 1997;12:100–107. PubMed PMID: 9229273.
  • King A. Increasing practitioner awareness of racial variations in colorectal cancer screening recommendations in African Americans. Doctor Nurs Practice (DNP) Project. 2017.
  • Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–1649. Epub 20150603. PubMed PMID: 26041752.
  • Muthukrishnan M, Arnold LD, James AS. Patients’ self-reported barriers to colon cancer screening in federally qualified health center settings. Prev Med Rep. 2019;15:100896. Epub 20190515. PubMed PMID: 31193550; PubMed Central PMCID: PMC6531912.
  • Wang H, Roy S, Kim J, Farazi PA, Siahpush M, Su D. Barriers of colorectal cancer screening in rural USA: a systematic review. Rural Remote Health. 2019;19:5181. Epub 20190809. PubMed PMID: 31394041.
  • Schoch ALC 2020. https://blogs.worldbank.org/opendata/number-poor-people-continues-rise-sub-saharan-africa-despite-slow-decline-poverty-rate
  • Eshemokha U 2020. https://nimedhealth.com.ng/2020/11/28/cost-of-colonoscopy-in-ghana/
  • Kwakye G, Dally CK. Colorectal cancer screening in sub-Saharan Africa. Lancet Glob Health. 2022;10:e938–9. PubMed PMID: 35714636.
  • Richardson H, Aronson KJ, James A, McGregor ES, Bryant H. Factors related to use of prostate cancer screening: the Alberta Tomorrow Project. Open Med. 2007;1:e3–12. Epub 20070414. PubMed PMID: 20101288; PubMed Central PMCID: PMC2801912.
  • Ortiz AP, Hebl S, Serrano R, Fernandez ME, Suárez E, Tortolero-Luna G. Factors associated with cervical cancer screening in Puerto Rico. Prev Chronic Dis. 2010;7: A58. Epub 20100415. PubMed PMID: 20394697; PubMed Central PMCID: PMC2879990.
  • Kazi E, Sareshwala S, Ansari Z, Sahota D, Katyal T, Tseng W, et al. Promoting colorectal cancer screening in South Asian Muslims Living in the USA. J Cancer Educ. 2021;36:865–873. PubMed PMID: 32279246.
  • Patel S, Kranick J, Manne S, Shah K, Raveis V, Ravenell J, et al. A population health equity approach reveals persisting disparities in colorectal cancer screening in New York City South Asian Communities. J Cancer Educ. 2021;36:804–810. PubMed PMID: 32060860; PubMed Central PMCID: PMC8685893.
  • Gede N, Reményi Kiss D, Kiss I. Colorectal cancer and screening awareness and sources of information in the Hungarian population. BMC Fam Pract. 2018;19:106. Epub 20180630 PubMed PMID: 29960585; PubMed Central PMCID: PMC6026511.
  • Bretthauer M, Løberg M, Wieszczy P, Kalager M, Emilsson L, Garborg K, et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. N Engl J Med. 2022;387:1547–1556. Epub 20221009. PubMed PMID: 36214590.